Cell Therapy Biomanufacturing Market Size, Share, By Product Type (Consumables, Equipment, Systems & Software), Cell Type (T-cell, Stem Cell, and Others), Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control, and Others), End User (Biopharmaceutical Biotechnology Companies, Research Institutes, Cell Banks, and Others), and Region - Trends, Analysis, and Forecast till 2035

Cell therapy biomanufacturing market size was valued at USD 11.0 Billion in 2025 and is expected to reach USD 30.3 Billion by 2035, growing at a CAGR of 11.8%

Cell therapy biomanufacturing is the process of creating large quantities of living cells for medical uses, including the treatment of cancer, autoimmune diseases, and genetic disorders.

The demand for personalized and regenerative medicines is driving the growth of the cell therapy biomanufacturing market, which is also being driven by an increasing number of clinical trials for cell-based therapies, advancements in cell processing technologies, and increased investment from biotech and pharmaceutical companies. Additionally, the rising prevalence of chronic and inherited diseases, supportive government initiatives, and developments in automation and scalability are propelling market expansion by lowering the cost and increasing the accessibility of cell therapies.